Viveve Medical, Inc. (VIVE)
OTCMKTS: VIVE · Delayed Price · USD
0.0004
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Viveve Medical Employees
Viveve Medical had 47 employees as of December 31, 2021. The number of employees increased by 5 or 11.90% compared to the previous year.
Employees
47
Change (1Y)
5
Growth (1Y)
11.90%
Revenue / Employee
$145,234
Profits / Employee
-$508,894
Market Cap
4.29K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
VIVE News
- 1 year ago - Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence - Accesswire
- 1 year ago - Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded - Accesswire
- 1 year ago - Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence - Accesswire
- 1 year ago - Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update - Accesswire
- 1 year ago - Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022 - Accesswire
- 1 year ago - Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence - Accesswire
- 1 year ago - Viveve to Participate in Ladenburg Thalmann Healthcare Conference - Accesswire
- 2 years ago - Viveve to Participate in Alliance Global Partners Virtual MedTech Conference - Accesswire